James L Heppell

Insider

First SEC filing: Jan. 23, 2018 · Latest: Jan. 23, 2018

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 9 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

9 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Oct. 10, 2018	SKYE	A	200,000	—	—	200,000 Direct	—	Acquired	(price as of 2026-08-21)
Aug. 14, 2008	INO	A	75,000	$1.03	$77,250	75,000 Direct	—	Acquired	-97.5% (price as of 2026-08-21)
May 2, 2008	INO	A	15,000	$0.89	$13,350	15,000 Direct	—	Acquired	-97.1% (price as of 2026-08-21)
May 4, 2007	INO	A	15,000	$3.75	$56,250	15,000 Direct	—	Acquired	-99.3% (price as of 2026-08-21)
June 7, 2006	INO	A	25,000	$2.23	$55,750	25,000 Direct	—	Acquired	-98.9% (price as of 2026-08-21)
May 13, 2005	INO	A	10,000	$3.34	$33,400	10,000 Direct	—	Acquired	-99.2% (price as of 2026-08-21)
Sept. 17, 2004	INO	P	1,029	$8.80	$9,055	1,029 Direct	—	Acquired	-99.7% (price as of 2026-08-21)
Sept. 17, 2004	INO	P	2	$11764.71	$23,529	2 Direct	—	Acquired	-100.0% (price as of 2026-08-21)
Aug. 6, 2004	INO	A	20,000	$0.93	$18,600	20,000 Direct	—	Acquired	-99.3% (price as of 2026-08-21)
June 17, 2004	INO	A	35,000	$1.33	$46,550	35,000 Direct	—	Acquired	-99.5% (price as of 2026-08-21)
Aug. 8, 2003	INO	A	111,250	$0.63	$70,088	331,250 Direct	+50.57%	Acquired	-99.0% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Oct. 10, 2018	SKYE	Director Stock Option (Right to Buy)	Common Stock (200,000)	$0.30	Oct. 10, 2028	200,000	Acquired
Aug. 14, 2008	INO	Inovio Biomedical Corporation Common Stock Option	Inovio Biomedical Corporation Common Stock (75,000)	$1.03	Aug. 14, 2018	75,000	Acquired
May 2, 2008	INO	Inovio Biomedical Corporation Common Stock Option	Inovio Biomedical Corporation Common Stock (15,000)	$0.89	May 2, 2018	15,000	Acquired
May 4, 2007	INO	Inovio Biomedical Corporation Common Stock Option	Inovio Biomedical Corporation Common Stock (15,000)	$3.75	May 4, 2017	15,000	Acquired
June 7, 2006	INO	Inovio Biomedical Corporation Common Stock Option	Inovio Biomedical Corporation Common Stock (25,000)	$2.23	June 7, 2016	25,000	Acquired
May 13, 2005	INO	Inovio Biomedical Corporation Common Stock	Inovio Biomedical Corporation Common Stock (10,000)	$3.34	May 12, 2015	10,000	Acquired
Sept. 17, 2004	INO	Genetronics Biomedical Corporation Common Stock Warrants	Genetronics Biomedical Corporation Commmon Stock	$8.80	May 10, 2009	1,029	Acquired
Aug. 6, 2004	INO	Common Stock	Common Stock (20,000)	$0.93	Aug. 5, 2014	20,000	Acquired
June 17, 2004	INO	Common Stock	Common Stock (35,000)	$1.33	June 16, 2014	35,000	Acquired
Aug. 8, 2003	INO	Common Stock	Common Stock (111,250)	$0.63	Aug. 7, 2013	111,250	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Jan. 23, 2018	SKYE	No securities beneficially owned.	0	Direct